$3.19
0.0551.75%
近くで: Sep 30, 5:00 PM EST
$3.14
-0.055-1.72%
時間外: 9:30 AM EST
Benzinga
Benzinga
Benzinga
水曜日, 9 30
Larimar Therapeutics Inc
LRMRNASDAQ
Larimar Therapeutics Earnings & Forecasts
Larimar Therapeutics (LRMR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Larimar Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.38 | $-0.56 | $-0.50 | $-0.41 |
| Actual | $-0.30 | $-0.31 | $-0.73 | $-0.61 |
| Surprise | +21.1% | +44.6% | -46.0% | -48.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.39 | $-0.36 | $-0.36 |
| Revenue | ||||
| Consensus | — | — | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved